Center for Digestive and Liver Diseases, Inc.  © 2013  |  Privacy policy

like us

 

Crohn's Disease

 
 

Protocol RHB-104-01

 

The investigators hypothesize that RHB-104 will have greater efficacy than placebo in Crohn's disease

 

A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease

 

 

 

I am interested in more information about this study.

SEND CLEAR